Evidence map›Paper›PMID 36305477›Full record

ArticleJournal of medical virology2023

Parents' willingness to vaccinate themselves and their children with the booster vaccine against SARS-CoV-2: A cross-sectional study in Puyang city, China.

Yiguo Zhou, Guo-Xing Li, Tian-Shuo Zhao, Juan Du, Wan-Xue Zhang, Ming-Zhu Xie, Lin-Yi Chen, Jing Zeng, Chao Wang, Bei Liu and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of medical virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Yiguo ZhouDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.
Guo-Xing LiDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.
Tian-Shuo ZhaoDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.
Juan DuDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.
Wan-Xue ZhangDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.
Ming-Zhu XieDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.
Lin-Yi ChenDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.
Jing ZengDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.
Chao WangDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.
Bei LiuDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.
Ya-Qiong LiuDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.
Fuqiang CuiDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.
Qing-Bin LuDepartment of Laboratorial Science and Technology, Vaccine Research Center, School of Public Health, Peking University, Beijing, People's Republic of China.ORCID 0000-0002-2804-0827
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to investigate the hesitancy and willingness of parents to vaccinate themselves and their children with a booster dose against severe acute respiratory syndrome coronavirus 2 and related factors. We conducted a cross-sectional study in Puyang city, China. The information was collected, including demographic characteristics, willingness to receive a booster dose of coronavirus disease 2019 (COVID-19) vaccine, and attitudes and concerns toward COVID-19 and vaccines. Vaccine hesitancy was assessed in individuals completing the first two doses and booster eligible, while vaccine willingness was assessed in those completing the first two doses and not yet booster eligible. Among the participants completing two primary doses while not meeting the booster criteria, 95.4% (1465/1536) and 95.0% (1385/1458) had a willingness to a booster dose of COVID-19 vaccine for themselves and their children, respectively. Among the participants who met the booster criteria, 40.3% had vaccine hesitancy. Vaccine hesitancy and unwillingness tended to occur in people who were younger, less educated, less healthy, and with unsureness of vaccines' efficacy and adverse events (AE). The younger age of children, children in poorer health, and concern about the efficacy and AE of vaccines contributed to the participants' unwillingness to vaccinate their children. We observed a high willingness to the booster dose of COVID-19 vaccine both for the parents and their children, regardless of the eligibility to a booster dose. However, 40% of people had delayed vaccination behaviors. The promotion of scientific knowledge of vaccines' effectiveness and safety is needed, especially for people in poor health and parents with young children. Timely disclosure of AE caused by COVID-19 vaccines and proper aiding offered to people encountering AE are suggested.

Indexed as

COVID-19SARS-CoV-2ChildChild, PreschoolChinaCOVID-19 VaccinesCross-Sectional StudiesHumansParentsVaccinationCOVID-19 Vaccinesbooster shotCOVID-19SARS-CoV-2vaccine hesitancywillingness

Identifiers

PMID36305477
PMCPMC9874889
OpenAlexW4307462274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.